Department of Medicine
Immunology and Infectious Disease | Infectious Disease | Microbiology | Therapeutics | Virus Diseases
The International Society for Vaccines (ISV) launched a virtual congress series www.ISVCongress.org as the leading platform for key COVID‐19 vaccine developersto share their progress and for the global vaccine community to contribute their collective expertise and wisdom about broader aspects of the global pandemic vaccine response. The aims were threefold: 1) to provide timely information about the processes put in place by regulatory agencies and NGOs for COVID-19 vaccine development, 2) to present primary data from groups developing vaccines, and 3) to provide a forum for discussion by experts about key challenges that confront the COVID-19 vaccine development process.
COVID-19, SARS-CoV-2, Vaccine, International Society for Vaccines
Rights and Permissions
© 2020 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
DOI of Published Version
Klavinskis L, Liu M, Lu S. A Timely Update of Global COVID-19 Vaccine Development. Emerg Microbes Infect. 2020 Oct 15:1-7. doi: 10.1080/22221751.2020.1838246. Epub ahead of print. PMID: 33059515. Link to article on publisher's site
Emerging microbes and infections
Klavinskis L, Liu M, Lu S. (2020). A Timely Update of Global COVID-19 Vaccine Development. COVID-19 Publications by UMMS Authors. https://doi.org/10.1080/22221751.2020.1838246. Retrieved from https://escholarship.umassmed.edu/covid19/134
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.